![]() |
![]() |
Legal status
Patent not validated
(51) | INT.CL. | A61K 31/155 | |
A61K 31/4184 | |||
A61K 31/522 | |||
A61P 3/10 |
(11) | Number of the document | 2640371 |
(13) | Kind of document | T |
(96) | European patent application number | 11787655.7 |
Date of filing the European patent application | 2011-11-15 | |
(97) | Date of publication of the European application | 2013-09-25 |
(45) | Date of publication and mention of the grant of the patent | 2020-01-08 |
(46) | Date of publication of the claims translation |
(86) | Number | PCT/EP2011/070156 |
Date | 2011-11-15 |
(87) | Number | WO 2012/065993 |
Date | 2012-05-24 |
(30) | Number | Date | Country code |
10191261 | 2010-11-15 | EP | |
415545 P | 2010-11-19 | US | |
421400 P | 2010-12-09 | US | |
11168317 | 2011-05-31 | EP | |
201161492391 P | 2011-06-02 | US | |
11170992 | 2011-06-22 | EP |
(72) |
KLEIN, Thomas, DE
DAIBER, Andreas, DE
JOHANSEN, Odd-Erik, DE
MARK, Michael, DE
PATEL, Sanjaykumar, DE
WOERLE, Hans-Juergen, DE
|
(73) |
Boehringer Ingelheim International GmbH,
Binger Strasse 173, 55216 Ingelheim am Rhein,
DE
|
(54) | VASOPROTECTIVE AND CARDIOPROTECTIVE ANTIDIABETIC THERAPY |
VASOPROTECTIVE AND CARDIOPROTECTIVE ANTIDIABETIC THERAPY |